A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...
The focus of the Electrophysiology Section and Section Leadership Council is on the specialties of cardiac electrophysiology and electrocardiography and includes all aspects of management and ...
On behalf of the ACPC leadership council, I extend a warm welcome to all our existing and new section members. I am pleased to update you on the exciting initiatives within our section that enhance ...
Whether you are a seasoned attendee or attending your first ACC Annual Scientific Session this year, don't miss the CV Team Section Town Hall, taking place ahead of ACC.25 on Wednesday, March 12 at ...
Check out a new slide lecture, "Cardiac Amyloidosis Foundations," as part of ACC's free online course, Cardiac Amyloidosis: Accelerating Diagnosis and Treatment. Learn to identify symptomology of ...
The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC. BPROAD: Support For Intensive BP Control in Type 2 Diabetes ...
The Centers for Medicare and Medicaid Services (CMS) created two new G codes in the 2025 Medicare Physician Fee Schedule final rule that will provide reimbursement for atherosclerotic cardiovascular ...
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. To aid in achieving this objective, a three-part Expert Panel ...
The American Heart Association (AHA) 2024 Scientific Sessions in Chicago provided a platform for sharing the latest advancements in interventional cardiology. Here we delve into some of the most ...
Imagine this: the selection committee for the Nobel Prize in Physiology or Medicine is set to honor an advancement in cardiology in 2025. The question is not whether cardiology deserves it – but ...
The lifetime risk of developing heart failure with reduced ejection fraction (HFrEF) is greater in men, while women are at greater risk of developing HF with preserved EF (HFpEF), according to 25-year ...
Lower extremity peripheral artery disease (PAD) is estimated to affect one of 10 Americans aged 40 years or older, with prevalence increasing with age. 1,2 Similar patterns are observed worldwide. 3 ...